Exploring Adipose Tissue Structure by Methylsalicylate Clearing and 3D Imaging
August 19th, 2020
Here, we describe a simple, inexpensive and fast clearing method to resolve the 3D structure of both mouse and human white adipose tissue using a combination of markers to visualize vasculature, nuclei, immune cells, neurons, and lipid-droplet coat proteins by fluorescent imaging.
Overview
This study presents a streamlined and cost-effective clearing method for visualizing the 3D structure of mouse and human white adipose tissue. The technique employs various markers for imaging vasculature, immune cells, and lipid droplets, offering insights into adipose tissue pathology.
Key Study Components
Research Area
- Adipose tissue visualization
- 3D imaging techniques
- Pathological analysis of adipose tissue
Background
- Importance of white adipose tissue in metabolism
- Need for improved imaging methods
- Comparison with existing clearing protocols
Methods Used
- Fluorescent imaging of fixed white adipose tissue
- Mouse and human adipose tissue models
- Utilization of less toxic solvents for clearing
Main Results
- Effective visualization of adipose tissue structures
- Enhanced image depth and clarity
- Facilitated identification of cell types and structures within adipose tissue
Conclusions
- This method significantly advances the understanding of adipose tissue structure in health and disease.
- It has potential applications in both basic and clinical research related to adipose tissue.
Frequently Asked Questions
Executive Industry Relevance
Understanding adipose tissue structural remodeling is critical for de-risking obesity-related therapeutic hypotheses. This clearing and 3D imaging method enables mechanistic visualization of adipocyte, vascular, immune, and neuronal networks, supporting target validation in metabolic disease research. By providing quantitative, reproducible structural readouts, it enhances predictive confidence in preclinical models of adipose tissue dysfunction.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of adipose tissue structural hypotheses linked to metabolic dysfunction.
- Operational Value: Uses accessible reagents and standard lab equipment for broad adoption.
- Strategic Value: Supports target de-risking by linking pathological phenotypes to 3D tissue architecture.
Screening & Assay Development
- Scientific Value: Generates standardized, quantitative 3D maps for assessing structural changes in adipose tissue.
- Operational Value: Compatible with fluorescent antibody panels for multiplexed cell type visualization.
- Strategic Value: Facilitates assay readiness for screening compounds that modulate adipose tissue remodeling.
Translational & Preclinical Research
- Scientific Value: Provides disease-relevant structural readouts in mouse and human adipose tissue models.
- Operational Value: Enables longitudinal tracking of tissue remodeling in preclinical studies.
- Strategic Value: Supports translational biomarker alignment through correlative imaging of vascular, immune, and adipocyte networks.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target hypothesis testing to preclinical validation by delivering structural phenotyping data that informs go/no-go decisions.
- Discovery Biology: Supports mechanistic de-risking by visualizing adipose tissue responses to genetic or pharmacological perturbations.
- Screening: Delivers reproducible, quantitative imaging outputs for evaluating compound effects on tissue architecture.
- Analytics: Enables measurement of adipocyte size distribution, vascular density, and immune cell localization as structural endpoints.
- Translational Research: Connects discovery findings to preclinical continuity through cross-species structural comparison.
- Enterprise Reuse: Establishes a reusable clearing and imaging platform for metabolic disease programs.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in adipose tissue pathology studies.
- Operational Value: Uses less toxic clearing agents and standard laboratory infrastructure.
- Strategic Value: Improves go/no-go decision confidence by providing direct structural readouts.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on adipose tissue remodeling phenotypes.
Implementation Considerations
- Requires expertise in tissue fixation, clearing, and fluorescent immunostaining.
- Needs access to a chemical hood, orbital shaker, temperature control, and fluorescent or confocal microscope.
- Demands standardization of staining and clearing timelines across laboratories for reproducibility.
- Requires adaptation of antibody panels for species-specific target visualization in mouse and human tissue.
- Limited by tissue size and clearing time, which may affect throughput for large sample cohorts.
Biopharma FAQs
Chapters in this video
0:04
Introduction
0:35
Mouse and Human White Adipose Tissue Fixation, Permeabilization, and Saturation
2:59
Mouse and Human White Adipose Tissue Staining
5:28
Mouse and Human White Adipose Tissue Clearing
6:17
3D Confocal Imaging
7:23
3D Adipose Tissue Image Quantitative Result Extraction
7:57
Results: Representative Adipose Tissue Labeling and Analysis
9:34
Conclusion
